CY1113403T1 - Νεος βιοδεικτης για την παρακολουθηση της εξελιξης των νοσων και την εκτιμηση της αποτελεσματικοτητας των θεραπειων - Google Patents
Νεος βιοδεικτης για την παρακολουθηση της εξελιξης των νοσων και την εκτιμηση της αποτελεσματικοτητας των θεραπειωνInfo
- Publication number
- CY1113403T1 CY1113403T1 CY20121100924T CY121100924T CY1113403T1 CY 1113403 T1 CY1113403 T1 CY 1113403T1 CY 20121100924 T CY20121100924 T CY 20121100924T CY 121100924 T CY121100924 T CY 121100924T CY 1113403 T1 CY1113403 T1 CY 1113403T1
- Authority
- CY
- Cyprus
- Prior art keywords
- monitoring
- therapies
- assessing
- evolution
- effectiveness
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 238000012544 monitoring process Methods 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 102100022464 5'-nucleotidase Human genes 0.000 abstract 2
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 abstract 2
- 239000012530 fluid Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- 239000000090 biomarker Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
- G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20070795A FI20070795A0 (fi) | 2007-10-24 | 2007-10-24 | Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin |
| EP08842581A EP2201376B1 (en) | 2007-10-24 | 2008-10-15 | A new biomarker for monitoring development of diseases and assessing the efficacy of therapies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1113403T1 true CY1113403T1 (el) | 2016-06-22 |
Family
ID=38656804
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20121100924T CY1113403T1 (el) | 2007-10-24 | 2012-10-04 | Νεος βιοδεικτης για την παρακολουθηση της εξελιξης των νοσων και την εκτιμηση της αποτελεσματικοτητας των θεραπειων |
| CY20151100234T CY1116089T1 (el) | 2007-10-24 | 2015-03-06 | Cd73 ως ενας βιοδεικτης για την παρακολουθηση της εξελιξης νοσων και εκτιμηση της αποτελεσματικοτητας θεραπειων |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20151100234T CY1116089T1 (el) | 2007-10-24 | 2015-03-06 | Cd73 ως ενας βιοδεικτης για την παρακολουθηση της εξελιξης νοσων και εκτιμηση της αποτελεσματικοτητας θεραπειων |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20100209942A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2201376B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP4982610B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20100059902A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2702635A1 (cg-RX-API-DMAC7.html) |
| CY (2) | CY1113403T1 (cg-RX-API-DMAC7.html) |
| DK (2) | DK2201376T3 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2532361T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI20070795A0 (cg-RX-API-DMAC7.html) |
| HR (2) | HRP20120743T1 (cg-RX-API-DMAC7.html) |
| PL (2) | PL2503338T3 (cg-RX-API-DMAC7.html) |
| PT (2) | PT2201376E (cg-RX-API-DMAC7.html) |
| SI (2) | SI2201376T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009053523A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5781767B2 (ja) | 2008-01-18 | 2015-09-24 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 体液中における疾患または状態のシグネチャーを検出する方法 |
| CA2806304A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
| US20130184178A1 (en) | 2010-07-23 | 2013-07-18 | President And Fellows Of Harvard College | Methods of Detecting Autoimmune or Immune-Related Diseases or Conditions |
| MX382244B (es) | 2010-07-23 | 2025-03-13 | Harvard College | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales |
| US20130210647A1 (en) | 2010-07-23 | 2013-08-15 | President And Fellows Of Harvard College | Methods of Detecting Cardiovascular Diseases or Conditions |
| US20120040846A1 (en) | 2010-07-23 | 2012-02-16 | President And Fellows Of Harvard College | Methods of Detecting Diseases or Conditions Using Phagocytic Cells |
| EP2861765B1 (en) | 2012-06-15 | 2019-01-23 | Progenity, Inc. | Methods of detecting diseases or conditions |
| CA2876711A1 (en) | 2012-06-15 | 2013-12-19 | Harry Stylli | Methods of detecting diseases or conditions using circulating diseased cells |
| CN105164535B (zh) | 2013-02-14 | 2018-04-10 | 法龙药品公司 | 测定急性呼吸窘迫综合征(ards)相关生物标志物的方法、监测患者的ards的发展和治疗的方法 |
| EP3385717A3 (en) | 2013-03-09 | 2018-10-24 | Harry Stylli | Methods of detecting prostate cancer |
| EP4202441A3 (en) | 2013-03-09 | 2023-07-26 | Immunis.AI, Inc. | Gene expression profile in macrophages for the diagnosis of cancer |
| EP3191846A4 (en) | 2014-09-11 | 2018-06-13 | Harry Stylli | Methods of detecting prostate cancer |
| WO2016081746A2 (en) | 2014-11-21 | 2016-05-26 | Bristol-Myers Squibb Company | Antibodies comprising modified heavy constant regions |
| ES2807182T3 (es) | 2014-11-21 | 2021-02-22 | Bristol Myers Squibb Co | Anticuerpos frente a CD73 y sus usos |
| GB201706747D0 (en) * | 2017-04-27 | 2017-06-14 | Queen Mary | Method and apparatus for determining the efficacy of statins for treating inflammatory diseases in idividual patients |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002515965A (ja) * | 1995-08-18 | 2002-05-28 | ダブリュー． ランドリ，ドナルド | 抗体触媒反応の調節による有機化合物の検出 |
| AU7310496A (en) | 1995-10-13 | 1997-04-30 | Imperial College Of Science, Technology And Medicine | Methods for predicting the outcome of persistent hbv infection and the outcome of cytokine therapy |
| HUP0002003A3 (en) | 2000-05-24 | 2003-01-28 | Pronuk Biotechnologia Kft | Process and reagent-kit for determining of 5'-nucleotidase activity |
| AU2002252460A1 (en) * | 2001-03-27 | 2002-10-08 | Zymogenetics, Inc. | Human cytokine receptor |
| WO2004079013A1 (en) * | 2003-03-03 | 2004-09-16 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Ecto-5’-nucleotidase (cd73) used in the diagnosis and the treatment of pancreatic cancer |
| FI20030467A0 (fi) * | 2003-03-28 | 2003-03-28 | Sirpa Jalkanen | Menetelmä tulehdustilojen hoitamiseen |
| DE602004027797D1 (de) * | 2003-03-28 | 2010-08-05 | Faron Pharmaceuticals Oy | Erhöhung des adenosin-spiegels durch cytokin-induzierte expression von cd73 |
| US7772192B2 (en) * | 2003-06-03 | 2010-08-10 | The Regents Of The University Of California | Compositions and methods for treatment of disease with acetylated disaccharides |
| WO2007025044A2 (en) * | 2005-08-24 | 2007-03-01 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| FI20051003A0 (fi) | 2005-10-07 | 2005-10-07 | Faron Pharmaceuticals Oy | Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi |
| WO2007107598A1 (en) * | 2006-03-21 | 2007-09-27 | Heinrich-Heine-Universität Düsseldorf | Phosphorylated a2a receptor agonists |
| CA2657576C (en) * | 2006-07-14 | 2023-10-31 | The Regents Of The University Of California | Cancer biomarkers and methods of use thereof |
-
2007
- 2007-10-24 FI FI20070795A patent/FI20070795A0/fi not_active Application Discontinuation
-
2008
- 2008-10-15 EP EP08842581A patent/EP2201376B1/en active Active
- 2008-10-15 SI SI200830723T patent/SI2201376T1/sl unknown
- 2008-10-15 HR HRP20120743AT patent/HRP20120743T1/hr unknown
- 2008-10-15 PT PT08842581T patent/PT2201376E/pt unknown
- 2008-10-15 KR KR1020107006430A patent/KR20100059902A/ko not_active Ceased
- 2008-10-15 DK DK08842581.4T patent/DK2201376T3/da active
- 2008-10-15 US US12/679,785 patent/US20100209942A1/en not_active Abandoned
- 2008-10-15 SI SI200831377T patent/SI2503338T1/sl unknown
- 2008-10-15 WO PCT/FI2008/050576 patent/WO2009053523A1/en not_active Ceased
- 2008-10-15 JP JP2010530497A patent/JP4982610B2/ja not_active Expired - Fee Related
- 2008-10-15 ES ES12002502.8T patent/ES2532361T3/es active Active
- 2008-10-15 PL PL12002502T patent/PL2503338T3/pl unknown
- 2008-10-15 PT PT12002502T patent/PT2503338E/pt unknown
- 2008-10-15 EP EP12002502.8A patent/EP2503338B1/en active Active
- 2008-10-15 ES ES08842581T patent/ES2389751T3/es active Active
- 2008-10-15 CA CA2702635A patent/CA2702635A1/en not_active Abandoned
- 2008-10-15 DK DK12002502T patent/DK2503338T3/en active
- 2008-10-15 PL PL08842581T patent/PL2201376T3/pl unknown
- 2008-10-15 KR KR1020167005473A patent/KR20160029869A/ko not_active Ceased
-
2012
- 2012-04-23 JP JP2012098081A patent/JP5619810B2/ja not_active Expired - Fee Related
- 2012-10-04 CY CY20121100924T patent/CY1113403T1/el unknown
-
2015
- 2015-02-16 HR HRP20150181TT patent/HRP20150181T1/hr unknown
- 2015-03-06 CY CY20151100234T patent/CY1116089T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2201376E (pt) | 2012-08-20 |
| ES2389751T3 (es) | 2012-10-31 |
| CY1116089T1 (el) | 2017-02-08 |
| KR20160029869A (ko) | 2016-03-15 |
| EP2201376A1 (en) | 2010-06-30 |
| JP4982610B2 (ja) | 2012-07-25 |
| CA2702635A1 (en) | 2009-04-30 |
| HRP20120743T1 (hr) | 2012-10-31 |
| JP2011501176A (ja) | 2011-01-06 |
| ES2532361T3 (es) | 2015-03-26 |
| US20100209942A1 (en) | 2010-08-19 |
| FI20070795A0 (fi) | 2007-10-24 |
| EP2503338A2 (en) | 2012-09-26 |
| EP2201376B1 (en) | 2012-08-08 |
| JP5619810B2 (ja) | 2014-11-05 |
| EP2201376A4 (en) | 2011-03-23 |
| DK2201376T3 (da) | 2012-10-15 |
| EP2503338A3 (en) | 2013-03-13 |
| EP2503338B1 (en) | 2014-12-24 |
| KR20100059902A (ko) | 2010-06-04 |
| DK2503338T3 (en) | 2015-03-09 |
| PL2201376T3 (pl) | 2013-01-31 |
| SI2503338T1 (sl) | 2015-06-30 |
| SI2201376T1 (sl) | 2012-09-28 |
| PL2503338T3 (pl) | 2015-06-30 |
| WO2009053523A1 (en) | 2009-04-30 |
| JP2012159514A (ja) | 2012-08-23 |
| PT2503338E (pt) | 2015-03-05 |
| HRP20150181T1 (hr) | 2015-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1113403T1 (el) | Νεος βιοδεικτης για την παρακολουθηση της εξελιξης των νοσων και την εκτιμηση της αποτελεσματικοτητας των θεραπειων | |
| EA201100965A1 (ru) | Биомаркеры для ингибиторов с антиангиогенной активностью | |
| CY1118566T1 (el) | Διαγνωση με χρηση ιντερφερονης τυπου 1 | |
| BR112015011359A2 (pt) | método para indicar uma presença ou não presença de câncer de próstata agressivo | |
| AR098155A1 (es) | Métodos para diagnosticar y tratar trastornos eosinofílicos | |
| CY1108829T1 (el) | Ενεργοποιηση ace2 για θεραπεια καρδιακης, πνευμονικης και νεφρικης ασθενειας και υπερτασης | |
| EA201190043A1 (ru) | Имидазопиразиновые ингибиторы syk | |
| DK1421215T3 (da) | Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA | |
| EP1913391A4 (en) | QUANTITATIVE ASSAYS FOR PDGFR IN BODY FLUIDS | |
| CY1118377T1 (el) | Syk αναστολεις ιμιδαζοπυραζινης | |
| BRPI0906683B8 (pt) | método para medir e caracterizar microvesículas em fluidos corporais humanos | |
| BR112014002975A2 (pt) | composições de biomarcador e métodos | |
| EA201100297A1 (ru) | Биотесты на белок polyq | |
| DE60329165D1 (de) | Detektion und/oder beobachtung von synuclein-assoziierten krankheiten | |
| CY1105322T1 (el) | Μεθοδοι και συνθεσεις για την ανιχνευση παθολογικων συμβαντων | |
| MX2022001087A (es) | Ergotioneina, s-metil-ergotioneina, y usos de las mismas. | |
| CY1110076T1 (el) | Μεθοδος για τον καθορισμο της δεκτικοτητας σε αναστολεις chk1 | |
| CY1122202T1 (el) | Προσδιορισμος κινδυνου για θεραπεια αντιβιοτικων σε ασθενεις οι οποιοι υποφερουν απο πρωτοπαθη μη μολυσματικη νοσο δια καθορισμου του επιπεδου προκαλσιτονινης | |
| MX377026B (es) | Biomarcadores para la progresión de enfermedades en melanoma. | |
| BR112015021507A2 (pt) | métodos e composições para o diagnóstico de pré-eclampsia | |
| ATE454465T1 (de) | In-vitro-verfahren zur identifizierung von verbindungen zur krebstherapie | |
| BR112013025197A2 (pt) | métodos para tratar doença de alzheimer e para avaliar a eficáca de uma terapia destinada a tratar doença de alzheimer | |
| ATE432997T1 (de) | Therapieüberwachung für tumoren unter benutzung acc133 mrna | |
| EA201490576A1 (ru) | Молекулярный маркер для ранней диагностики мезотелиомы плевры у пациентов и способы для анализа его экспрессии | |
| ATE470153T1 (de) | Diagnostische verfahren für therapeutische verbindungen sowie verfahren zur überwachung der azathioprin-therapie |